Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
1. County of Los Angeles Department of Public Health, the Emergency Medical Services Agency of the Los Angeles County Department of Health Services. Terrorism Agent Information and Treatment Guidelines for Clinicians and Hospitals. Los Angeles, CA: County of Los Angeles Public Health; 2012.
2. Centers for Disease Control and Prevention. Medical Management Guidelines for Nerve Agents: Tabun (GA); Sarin (GB); Soman (GD); and VX. Available at https://www.atsdr.cdc.gov/mhmi/mmg166.pdf. Last accessed May 17, 2021.
3. 3. White SM. Chemical and biological weapons: implications for anaesthesia and intensive care. Br J Anaesth. 2002;89(2):306-324.
4. 4. Centers for Disease Control and Prevention. Laboratory Response Network for Chemical Threats (LRN-C). Available athttps://emergency.cdc.gov/lrn/chemical.asp. Last accessed May 17, 2021.
5. 5. Ferguson CD, Potter WC. Improvised Nuclear Devices and Nuclear Terrorism. Stockholm: Weapons of Mass Destruction Commission to the United Nations; 2005.
6. 6. Nuclear Energy Institute, Electric Power Research Institute. Deterring Terrorism: Aircraft Crash Impact Analyses Demonstrate Nuclear Power Plant's Structural Strength. Washington, DC: Nuclear Energy Institute; 2002
7. 7. Centers for Disease Control and Prevention. Acute Radiation Syndrome: A Fact Sheet for Clinicians. Available athttps://emergency.cdc.gov/radiation/arsphysicianfactsheet.asp. Last accessed May 17, 2021.
8. 8. Meridian Medical Technologies, Inc. ATNAA Atropine and Pralidoxime Chloride Auto-Injector. Available at https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=596c7a8f-27cd-4de2-9491-476f43570b8b&type=display. Last accessed May 17, 2021.
9. 9. U.S. Food and Drug Administration. DuoDote (Atropine and Pralidoxime Chloride Injection) for Intramuscular Use. Available athttps://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021983s023lbl.pdf. Last accessed May 17, 2021.
10. 10. U.S. Department of Health and Human Services. Nerve Agent Treatment: Autoinjector Instructions. Available athttps://chemm.nlm.nih.gov/antidote_nerveagents.htm. Last accessed May 17, 2021.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.